Yubing Wang | Oncology | Best Researcher Award

Assoc. Prof. Dr. Yubing Wang | Oncology | Best Researcher Award

Weifang No.2 People’s Hospital | China

AUTHOR PROFILE

Scopus

🔬 EARLY ACADEMIC PURSUITS

Yubing Wang embarked on his academic journey with a strong foundation in biosciences. In 2007, he earned his Bachelor’s degree in Bioscience from Shandong University, which laid the groundwork for his future endeavors in the field of biological and medical sciences. His passion for scientific research led him to pursue further studies, culminating in a Doctor of Science degree from The Chinese University of Hong Kong in 2017. This rigorous academic training provided him with expertise in advanced biological sciences and research methodologies, setting the stage for his future contributions to medical and bioscience research.

🏥 PROFESSIONAL ENDEAVORS

Dr. Wang’s professional career is marked by significant roles in both research and academia. His journey began as a Research Assistant at the Shanghai Institutes for Biological Sciences, CAS, where he worked for six years (2007–2013), gaining hands-on experience in cutting-edge biological research. Following this, he transitioned into academia, taking on the role of Associate Professor at Shandong Second Medical University from 2018 to 2023. His commitment to teaching and research was further recognized when he joined Weifang No.2 People’s Hospital as an Associate Professor in 2023, where he continues to contribute to the advancement of medical sciences.

đź“š CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY

Dr. Wang’s research is centered around biosciences and medical applications, particularly in biological mechanisms and therapeutic developments. His work has contributed to a deeper understanding of biomedical sciences, with a focus on improving clinical outcomes through innovative research. His interdisciplinary approach combines molecular biology, biotechnology, and clinical applications, addressing critical medical challenges and advancing healthcare solutions.

🌍 IMPACT AND INFLUENCE

Throughout his career, Dr. Wang has played a pivotal role in bridging the gap between fundamental bioscience research and its practical applications in medicine. His work has influenced both the academic community and clinical practices, contributing to the development of novel medical treatments and diagnostic tools. By mentoring students and collaborating with fellow researchers, he has fostered a new generation of scientists committed to pushing the boundaries of medical research.

đź“– ACADEMIC CITATIONS AND RECOGNITION

Dr. Wang’s research has been widely recognized in the academic community, with numerous scientific publications in reputed journals. His work has been cited by fellow researchers, reflecting the significance and impact of his contributions to biosciences and medical research. His research has also been instrumental in guiding clinical practices and informing new treatment methodologies.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

As an esteemed academic and researcher, Dr. Wang continues to expand his influence in bioscience and medical research. His future endeavors aim to enhance interdisciplinary research collaborations, further the development of innovative healthcare solutions, and mentor the next generation of scientists and medical professionals. His work at Weifang No.2 People’s Hospital is expected to drive forward transformative research, ultimately improving patient care and advancing medical knowledge.

🏆 CONCLUSION

Dr. Yubing Wang’s career exemplifies a commitment to scientific excellence, academic mentorship, and transformative medical research. His contributions in biosciences and medicine have left a lasting impact on both academia and clinical practice. With his expertise and dedication, he continues to shape the future of biomedical research, paving the way for groundbreaking discoveries and improved healthcare outcomes. His legacy as a researcher and educator ensures that his influence will be felt for generations to come.

 

📊🔬NOTABLE PUBLICATION:
  1. Title: Improved efficacy of cisplatin delivery by peanut agglutinin‑modified liposomes in non‑small cell lung cancer
    Authors: B., Yang, Ben , R., Kou, Rongguan , H., Wang, Hui , … W., Yu, Wenjing , Z., Gao, Zhiqin
    Journal: International Journal of Molecular Medicine
    Year: 2024

 

  1. Title: Novel analgesic peptide derived from Cinobufacini injection suppressing inflammation and pain via ERK1/2/COX-2 pathway
    Authors: L., Guo, Li , S., Zhang, Sai , C., Zhang, Cong , … Y., Gao, Yuanyuan , T., Sun, Tongyi
    Journal: International Immunopharmacology
    Year: 2024

Dr. Sumaira Mubarik – Cancer Science – Best Researcher Award

Dr. Sumaira Mubarik - Cancer Science - Best Researcher Award

University of Groningen - Netherlands

AUTHOR PROFILE

Scopus

Orcid

EARLY ACADEMIC PURSUITS:

Summaira Mubarik embarked on her academic journey with a strong foundation in mathematics, statistics, and computer science. She pursued her Bachelor of Science degree from Punjab University, Pakistan, specializing in Mathematics, Statistics, and Computer Science, which laid the groundwork for her future academic pursuits. Following this, she completed her FSc in Mathematics, Statistics, and Computer Science from BISE, Rawalpindi, Pakistan, further honing her analytical skills and preparing for advanced studies.

PROFESSIONAL ENDEAVORS:

Building upon her educational background, Mubarik pursued higher studies in statistics, earning her Master of Science degree from Arid Agriculture University Rawalpindi, Pakistan, in 2009. Subsequently, she completed her M.Phil, specializing in Statistics, from the same institution in 2012, where she conducted research on Quantile Regression Analysis of Blood Pressure levels for different factors of Adults under the supervision of Dr. Abdush Shakoor. These endeavors marked her entry into the realm of statistical research and analysis.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER SCIENCE

Mubarik's academic journey reached new heights when she pursued her PhD in Statistics at Wuhan University, China, from 2019 to 2021. Under the supervision of Prof. Chuanhua Yu, she delved into the domain of stochastic modeling and prediction of breast cancer risk transitions using the age-period-cohort framework. Her research not only showcased her expertise in applied statistics but also demonstrated a deep commitment to addressing critical issues in biostatistics and epidemiology.

IMPACT AND INFLUENCE:

Throughout her academic career, Mubarik has made significant contributions to the field of statistics, particularly in applied statistics, biostatistics, and disease modeling. Her research endeavors have the potential to impact public health policies and interventions aimed at mitigating the risk of breast cancer. Additionally, her work in stochastic mortality models and survival analysis holds promise for improving our understanding of disease progression and mortality patterns.

ACADEMIC CITATIONS:

Mubarik's research output has garnered attention and recognition within the academic community, as evidenced by her receipt of prestigious scholarships and awards. She was awarded the "Excellent International Student Award" from the Ministry of Education, China, in 2020, along with the Wuhan University Outstanding International Students Scholarship in 2020 and 2021 for her exceptional academic achievements.

LEGACY AND FUTURE CONTRIBUTIONS:

As an Assistant Professor at the University of Groningen, Netherlands, Mubarik continues to pursue her passion for statistics and research. Her expertise in pharma data science and statistics equips her to contribute significantly to the advancement of statistical methodologies in pharmaceutical research and healthcare. With a strong foundation in applied statistics and a focus on epidemiological modeling, Mubarik's future contributions hold the potential to shape the landscape of public health research and policy.

NOTABLE PUBLICATIONS

Estimating disparities of prostate cancer burden and its attributable risk factors for males across the BRICS-plus, 1990–2019: A comparable study of key nations with emerging economies. 2024 (1)

Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. 2024 (5)

Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021. 2024 (1)

Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021. 2024 (4)

Temporal patterns of cancer burden in Asia, 1990–2019: a systematic examination for the Global Burden of Disease 2019 study 2024

Assoc Prof Dr.Tiruveedula Gopi Krishna – Cancer Science – Best Researcher Award

Assoc Prof Dr.Tiruveedula Gopi Krishna - Cancer Science - Best Researcher Award

Adama Science and Technology University - Ethiopia

AUTHOR PROFILE

Google Scholar

Orcid

EARLY ACADEMIC PURSUITS

Dr. Tiruveedula Gopikrishna began his academic journey in the field of Computer Science and Engineering. His early academic pursuits laid the foundation for his future contributions in the realm of technology and information sciences.

PROFESSIONAL ENDEAVORS

Having demonstrated a keen interest in the field, Dr. Gopikrishna embarked on a professional journey that led him to the position of Assistant Professor and subsequently Associate Professor at Adama Science & Technology University in Ethiopia. His commitment to academia reflects in his multifaceted roles and responsibilities.

CONTRIBUTIONS AND RESEARCH FOCUS ON CANCER SCIENCE

Dr. Gopikrishna's expertise encompasses a diverse range of subjects, including Data Science, Big Data, Artificial Intelligence, Machine Learning, Deep Learning, Distributed Systems, Data Warehousing, Data Mining, Cloud Computing, C, Python, C++, Java, Web Technologies, and SQL. His research focus extends to critical areas such as Big Data Analytics and Visualization, Software Testing Methodologies, Middleware, and the intersection of big data with cloud computing.

IMPACT AND INFLUENCE

Dr. Gopikrishna's impact is evident in the significant contributions he has made to the academic and research community. His influence extends beyond the classroom, shaping the minds of aspiring technologists and researchers under his guidance.

ACADEMIC CITES

The academic prowess of Dr. Gopikrishna is underscored by his extensive experience in teaching undergraduate and postgraduate subjects. He has been instrumental in guiding 56 undergraduate projects and supervising 4 master's degree theses, showcasing his commitment to fostering academic excellence.

LEGACY AND FUTURE CONTRIBUTIONS

As an Associate Professor, Dr. Gopikrishna has already established a legacy in academia. His dedication to shaping the next generation of tech professionals and researchers is evident. Looking forward, his future contributions are poised to further enrich the fields of Computer Science and Information Technology, leaving an indelible mark on the academic landscape.

NOTABLE PUBLICATIONS

An Improved Switch Migration Method Based Efficient Load Balancing for Multiple Controllers in Software Defined Network. 2023

DDoS Attack Detection and Classification Using Hybrid Model for Multi-controller SDN. 2023 (3)

Classification of Brain Tumor Types on Magnetic Resonance Images Using Hybrid Deep Learning Approach with Radial Basis Function Neural Network. 2022

Breast Cancer Classification from Mammogram Images Using Extreme Learning Machine-Based DenseNet121 Model. 2022 (5)

Designing and Developing Bilingual Chatbot for AssistingEthio-Telecom Customers on Customer Services. 2022